Registry data as of Aug 27, 2026

Mary Milam, MD

Hematology & Oncology Physician · Fort Worth, TX

Mary Milam, MD is a hematology & oncology physician with a practice address in Fort Worth, Texas, and NPI 1063415735, issued on May 24, 2005. Check the license (Texas E4529, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, loaded Aug 27, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordas of Aug 27, 2026
1063415735
Name
Mary Milam
Credential
MD
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
E4529 TX
Self-reported in NPPES; status is on the state search
Practice location
1307 8TH Ave, Fort Worth, TX 76104
Phone
(817) 924-4300
Enumerated
May 24, 2005
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1307 8TH Ave

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Hollis Bartels, M.D.Student in an Organized Health Care Education/Training Program1720490758
  2. Nathaniel Byford, DPTPhysical Therapist1922481357
  3. Sherryl CummingsProfessional Counselor1689024002
  4. Ligia Dickerson, LOTOccupational Therapist1659700409
  5. Arthur Garcia, MDSpecialist1114971124
  6. Christopher Hinds, M.R.C. LPC CRCProfessional Counselor1326466673

Verify Mary Milam in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license E4529
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

86% more Medicare Part D claims than the average hematology & oncology physician in 2024

1,644 Medicare Part D claims for 291 beneficiaries, against an average of 885 among the 8,428 providers of this specialty who prescribed in Part D. 60 claims were for opioids.

  1. Mary Milam1,644
  2. Specialty average885

Most prescribed

  1. Levothyroxine Sodium169 claims
  2. Eliquis77 claims
  3. Allopurinol67 claims
  4. Ondansetron Hcl58 claims
  5. Warfarin Sodium55 claims
  6. Megestrol Acetate54 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The Medicare quality score for 2023: 89.5 of 100

The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score73.0
  2. Costout of 100 · 30%
  3. Promoting interoperabilityout of 100 · 25%
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $3,726.42

190 payments, mostly food and beverage; the largest payer was Pfizer Inc.. The 6,678 providers of this specialty with any payment received $7,643.36 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Mary Milam$3,726.42
  2. Specialty average$7,643.36

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Hematology & Oncology Physician providers in Texas

There are 637 hematology & oncology physician records in Texas.

Other hematology & oncology physician records in Texas

  1. Elham Abbasi-Hafshejani, M.D.The Woodlands, TX1306856513
  2. Muhammad Abid, M.D.Lubbock, TX1639480437
  3. Ambrose Aboud, MDEl Paso, TX1407843873
  4. Joel Abramowitz, M.D., PHDHouston, TX1447220413
  5. John Adams, DOArlington, TX1548262900
  6. Kerin Adelson, M.D.Houston, TX1285846790
  7. Vahid Afsharkharghan, M.D.Houston, TX1508958166
  8. Asim Ahmad, MDFort Worth, TX1447544838
  9. Munir AhmadLufkin, TX1881618957
  10. Faheem Ahmed, M.D.Lakeway, TX1538163860

Common questions

What is Mary Milam, MD's NPI number?

Mary Milam, MD's National Provider Identifier (NPI) is 1063415735, issued on May 24, 2005. An NPI identifies a provider in billing; it is not a license.

Where is Mary Milam, MD located?

The NPPES record lists a practice address at 1307 8TH Ave, Fort Worth, TX, 76104. Phone: (817) 924-4300. Providers update this record themselves, so call before visiting.

How can I verify Mary Milam, MD's license?

NPPES lists Texas license number E4529, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Mary Milam, MD prescribe under Medicare Part D?

In 2024, Mary Milam, MD had 1,644 Medicare Part D claims for 291 beneficiaries; the average among hematology & oncology physician prescribers was 885. Part D covers Medicare prescriptions only.

What is Mary Milam, MD's Medicare quality score?

The 2023 MIPS final score is 89.5 of 100. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.